Review
doi: 10.1016/j.ajog.2009.10.863.
Epub 2009 Dec 23.
Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications
Affiliations
- PMID: 20031112
- DOI: 10.1016/j.ajog.2009.10.863
Item in Clipboard
Review
Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications
Am J Obstet Gynecol.
2010 May.
Abstract
Intrauterine progestins, progesterone receptor modulators, and antagonists have many important current and potential gynecologic applications. This article will describe the evidence for use of intrauterine progestin for common gynecologic conditions beyond its important role in contraception. We will review the evidence for use of intrauterine progestin delivery for menorrhagia, endometriosis management, adenomyosis treatment, uterine fibroids, endometrial hyperplasia, and its concurrent use in women on hormone replacement therapy or tamoxifen.
Copyright (c) 2010 Mosby, Inc. All rights reserved.
Similar articles
-
Progestin-releasing intrauterine systems and leiomyoma.Contraception. 2007 Jun;75(6 Suppl):S130-3. doi: 10.1016/j.contraception.2007.01.012. Epub 2007 Mar 9. Contraception. 2007. PMID: 17531604 Review.
-
Levonorgestrel-releasing intrauterine system: uses and controversies.Expert Rev Med Devices. 2008 Jul;5(4):437-45. doi: 10.1586/17434440.5.4.437. Expert Rev Med Devices. 2008. PMID: 18573044 Review.
-
Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.Int J Gynecol Pathol. 2008 Jan;27(1):74-8. doi: 10.1097/pgp.0b013e318134ebcc. Int J Gynecol Pathol. 2008. PMID: 18156979
-
[Methods and efficacy of medical and surgical treatment of non functional menorrhagia].J Gynecol Obstet Biol Reprod (Paris). 2008 Dec;37 Suppl 8:S368-83. doi: 10.1016/S0368-2315(08)74778-1. J Gynecol Obstet Biol Reprod (Paris). 2008. PMID: 19268216 French.
-
Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system.Contraception. 2010 Nov;82(5):435-41. doi: 10.1016/j.contraception.2010.05.006. Epub 2010 Jun 20. Contraception. 2010. PMID: 20933117 Review.
Cited by
-
Recent scientific advances in leiomyoma (uterine fibroids) research facilitates better understanding and management.F1000Res. 2015 Jul 6;4(F1000 Faculty Rev):183. doi: 10.12688/f1000research.6189.1. eCollection 2015. F1000Res. 2015. PMID: 26236472 Free PMC article. Review.
-
The endometrial lymphatic vasculature: function and dysfunction.Rev Endocr Metab Disord. 2012 Dec;13(4):265-75. doi: 10.1007/s11154-012-9224-6. Rev Endocr Metab Disord. 2012. PMID: 23054374 Review.
-
Dilated thin-walled blood and lymphatic vessels in human endometrium: a potential role for VEGF-D in progestin-induced break-through bleeding.PLoS One. 2012;7(2):e30916. doi: 10.1371/journal.pone.0030916. Epub 2012 Feb 17. PLoS One. 2012. PMID: 22383980 Free PMC article.
-
Treatment for Uterine Fibroids: Searching for Effective Drug Therapies.Drug Discov Today Ther Strateg. 2012;9(1):e41-e49. doi: 10.1016/j.ddstr.2012.06.001. Drug Discov Today Ther Strateg. 2012. PMID: 23264802 Free PMC article.
-
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).Cochrane Database Syst Rev. 2020 Nov 23;11(11):CD008994. doi: 10.1002/14651858.CD008994.pub3. Cochrane Database Syst Rev. 2020. PMID: 33226133 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
